Showing 1 - 8 results of 8 for search 'Katherine R. Calvo', query time: 0.03s Refine Results
  1. 1
    IMPLICATIONS OF NOVEL CLASSIFICATIONS OF MYELOID NEOPLASMS FOR CHILDHOOD MDS

    IMPLICATIONS OF NOVEL CLASSIFICATIONS OF MYELOID NEOPLASMS FOR CHILDHOOD MDS by Katherine R. Calvo

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Myelodysplasia in the setting of paroxysmal nocturnal hemoglobinuria: Interpretation of blast percentage in a marrow with erythroid hyperplasia

    Myelodysplasia in the setting of paroxysmal nocturnal hemoglobinuria: Interpretation of blast percentage in a marrow with erythroid hyperplasia by Emma M. Groarke, Bhavisha A. Patel, Alina Dulau‐Florea, Irina Maric, Neal S. Young, Katherine R. Calvo

    Published 2020-11-01
    Get full text
    Article
  3. 3
    Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation

    Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation by Lisa J. McReynolds, Yubo Zhang, Yanqin Yang, Jingrong Tang, Matthew Mulé, Amy P. Hsu, Danielle M. Townsley, Robert R. West, Jun Zhu, Dennis D. Hickstein, Steven M. Holland, Katherine R. Calvo, Christopher S. Hourigan

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

    Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia by James L Gulley, Thomas Hughes, Jennifer L Marté, Katherine R Calvo, Meghali Goswami, Christopher S Hourigan, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, Catherine Lai

    Published 2022-01-01
    Get full text
    Article
  5. 5
    A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome

    A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome by David H. McDermott, Daniel Velez, Elena Cho, Edward W. Cowen, John J. DiGiovanna, Diana V. Pastrana, Christopher B. Buck, Katherine R. Calvo, Pamela J. Gardner, Sergio D. Rosenzweig, Pamela Stratton, Melissa A. Merideth, H. Jeffrey Kim, Carmen Brewer, James D. Katz, Douglas B. Kuhns, Harry L. Malech, Dean Follmann, Michael P. Fay, Philip M. Murphy

    Published 2023-10-01
    Get full text
    Article
  6. 6
    The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort

    The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort by Karyl S. Barron, Ivona Aksentijevich, Natalie T. Deuitch, Deborah L. Stone, Patrycja Hoffmann, Ryan Videgar-Laird, Ariane Soldatos, Jenna Bergerson, Camilo Toro, Cornelia Cudrici, Michele Nehrebecky, Tina Romeo, Anne Jones, Manfred Boehm, Jennifer A. Kanakry, Dimana Dimitrova, Katherine R. Calvo, Hawwa Alao, Devika Kapuria, Gil Ben-Yakov, Dominique C. Pichard, Londa Hathaway, Alessandra Brofferio, Elisa McRae, Natalia Sampaio Moura, Oskar Schnappauf, Sofia Rosenzweig, Theo Heller, Edward W. Cowen, Daniel L. Kastner, Amanda K. Ombrello

    Published 2022-01-01
    Get full text
    Article
  7. 7
    An immune-based biomarker signature is associated with mortality in COVID-19 patients

    An immune-based biomarker signature is associated with mortality in COVID-19 patients by Michael S. Abers, Ottavia M. Delmonte, Emily E. Ricotta, Jonathan Fintzi, Danielle L. Fink, Adriana A. Almeida de Jesus, Kol A. Zarember, Sara Alehashemi, Vasileios Oikonomou, Jigar V. Desai, Scott W. Canna, Bita Shakoory, Kerry Dobbs, Luisa Imberti, Alessandra Sottini, Eugenia Quiros-Roldan, Francesco Castelli, Camillo Rossi, Duilio Brugnoni, Andrea Biondi, Laura Rachele Bettini, Mariella D’Angio’, Paolo Bonfanti, Riccardo Castagnoli, Daniela Montagna, Amelia Licari, Gian Luigi Marseglia, Emily F. Gliniewicz, Elana Shaw, Dana E. Kahle, Andre T. Rastegar, Michael Stack, Katherine Myint-Hpu, Susan L. Levinson, Mark J. DiNubile, Daniel W. Chertow, Peter D. Burbelo, Jeffrey I. Cohen, Katherine R. Calvo, John S. Tsang, NIAID COVID-19 Consortium, Helen C. Su, John I. Gallin, Douglas B. Kuhns, Raphaela Goldbach-Mansky, Michail S. Lionakis, Luigi D. Notarangelo

    Published 2021-01-01
    Get full text
    Article
  8. 8
    Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome

    Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome by Adriana A. de Jesus, Guibin Chen, Dan Yang, Tomas Brdicka, Natasha M. Ruth, David Bennin, Dita Cebecauerova, Hana Malcova, Helen Freeman, Neil Martin, Karel Svojgr, Murray H. Passo, Farzana Bhuyan, Sara Alehashemi, Andre T. Rastegar, Katsiaryna Uss, Lela Kardava, Bernadette Marrero, Iris Duric, Ebun Omoyinmi, Petra Peldova, Chyi-Chia Richard Lee, David E. Kleiner, Colleen M. Hadigan, Stephen M. Hewitt, Stefania Pittaluga, Carmelo Carmona-Rivera, Katherine R. Calvo, Nirali Shah, Miroslava Balascakova, Danielle L. Fink, Radana Kotalova, Zuzana Parackova, Lucie Peterkova, Daniela Kuzilkova, Vit Campr, Lucie Sramkova, Angelique Biancotto, Stephen R. Brooks, Cameron Manes, Eric Meffre, Rebecca L. Harper, Hyesun Kuehn, Mariana J. Kaplan, Paul Brogan, Sergio D. Rosenzweig, Melinda Merchant, Zuoming Deng, Anna Huttenlocher, Susan L. Moir, Douglas B. Kuhns, Manfred Boehm, Karolina Skvarova Kramarzova, Raphaela Goldbach-Mansky

    Published 2023-03-01
    Get full text
    Article

Search Tools: